Institution: “Grigore T. Popa” University of Medicine and Pharmacy
Location: Iași, Romania
Adrian Covic is a Professor of Nephrology and Internal Medicine at the “Grigore T. Popa” University of Medicine and Pharmacy, the Director of the Nephrology Clinic and the Dialysis and Transplantation Center in Iasi, Romania. In the past he served as President of the Romanian Society of Nephrology and Secretary Treasurer of ERA-EDTA.
Prof. Covic started his clinical and research activity as a fellow in Nephrology in Manchester and Amiens. Later he performed clinical research at the Case Western University in Cleveland, Ohio. He received a Ph.D. on: “Cardiovascular abnormalities and its determinant factors in chronic renal failure” in 1997. Since 2007, he is a FRCP (London) and became in 2009 a member of the Romanian Academy of Medical Sciences. From 2011 he is also a Fellow of the ERA EDTA (FERA).
Prof. Covic published more than 410 original and review papers in peer-reviewed journals, 14 books and 22 chapters. The current Hirsch Index is 48.
He is an Associate Editor for NDT, and Editor in Chief (Nephrology) for the International Journal of Urology and Nephrology, and editor / reviewer for several prestigious journals.
His main areas of interest are: cardiovascular complications in renal disease, CKD-MBD, renal anaemia, peritoneal dialysis, and acute renal failure.
Prof. Covic is the Vice-Rector (Research) of the University of Medicine “Gr. T. POPA” Iasi, Romania and a board member of KDIGO, ERBP, and ERA-EDTA working groups – EURECAM and CKD-MBD.
Prof Covic has organized several regional European educational courses under the auspices of ERA EDTA and ISN. For a mandate he has been chair of the ISN/COMGAN Eastern Europe.
Sophie de Seigneux
Institution: University Hospital of Geneva
Location: Geneva, Switzerland
Sophie de Seigneux has been Assistant Professor in the Department of Internal Medicine for Specialties of the Faculty of Medicine since 2015. She studied medicine in Geneva, completed by a specialization in internal medicine. She studied renal pathophysiology in Aarhus, Denmark, where she obtained a PhD. She then continued her specialization in nephrology in Geneva and Paris. Since 2009, she has been combining clinical medicine and fundamental research, as head of a scientific clinic, then as an Ambizione grant holder from the SNSF. Since 2011, she has also been part of a Swiss national research center in nephrology (NCCR. Kidney.ch).
Her research focuses on the pathophysiology and monitoring of acute kidney injury and chronic kidney diseases, two common and disabling diseases, and their complications. More specifically, she is interested in the role of tubular cells in determining potential new therapeutic targets, as well as in the diagnosis and non-invasive monitoring of kidney disease. Appointed privat-docent of the Faculty of Medicine and associate physician in the Nephrology Department of the HUG in 2014, she obtained the same year a grant from the SNSF professor. She was appointed Assistant Professor in the Department of Internal Medicine for Specialties of the Faculty of Medicine in October 2015.
An De Vriese
Institution: AZ Sint-Jan
Location: Brugge, Belgium
An De Vriese is head of the Department of Internal Medicine and of the Division of Nephrology and Infectious Disease in AZ Sint-Jan Brugge.
She is author of over 140 publications in peer-reviewed medical journals. Her interest is focussed on clinical studies in hemodialysis and peritoneal dialysis.
An De Vriese received her degree in Medicine summa cum laude from the Ghent University in 1992. She also studied at the University of the Free State, Bloemfontein, RSA and performed research at the Institute for Anatomy and Cell Biology, Ruprecht-Karls-University, Heidelberg, and at the Institute de Recherches Servier, Paris. She was Research Assistant of the Belgian National Fund for Scientific Research and obtained a Ph.D. in Medical Science in 2001.
Institution: University Clinic of Saarland
Location: Homburg/Saar, Germany
Danilo Fliser has been the Director of the Internal Medicine Clinic IV at the University Clinic of Saarland since 2007.
He has won the following German research prizes:
2005 – Franz Volhard Prize
2004 – Bernd Tersteegen Prize
1995 – Nils Alwall Prize
Institution: University Claude Bernard Lyon 1 and Centre Hospitalier Lyon Sud
Location: Lyon, France
Denis Fouque is Professor of Nephrology at the University Claude Bernard Lyon1, and Associate Chief of the Division of Nephrology at the Centre Hospitalier Lyon Sud in Lyon, France. He is the past Research Vice President (Health Affairs) at the Université Claude Bernard Lyon, the largest medical school in France (2012-2016). Dr Fouque has published 280 papers, including reviews, meta-analyses and 18 book chapters, among which 2 chapters in The Kidney, Brenner and Rector, 2012 and 2015. His current h factor is 52. His research fields are in nutrition and metabolism in chronic kidney disease and dialysis. He is director of the adipocyte dysfunction research group in INSERM 1060 at the University Claude Bernard Lyon1. Dr Fouque also got training in Evidence based Medicine by founding the Cochrane Collaboration Renal Group in 1997 and being the Co-ordinating Editor until 2001. Dr Fouque was President of the International Society for Renal Nutrition and Metabolism (2004–2006), Editor-in-Chief of the Journal of Renal Nutrition (2003-2011) and chairman of the ERA-EDTA Nutrition Guideline (2007). Dr Fouque is currently vice-chairman of the European Renal Best Practice group of ERA-EDTA. He has been an ERA-EDTA Council member from 2012 to 2015, and is the Editor-in-chief elect of Nephrology Dialysis Transplantation.
Institution: Erasmus Medical Center
Location: Rotterdam, Netherlands
Ewout Hoorn is Professor of Nephrology at the Erasmus Medical Center in Rotterdam, the Netherlands. His research interests include basic and clinical aspects of renal tubular transport and the link with human disease, including electrolyte disorders, hypertension, and chronic kidney disease. He coordinates a tertiary referral clinical for renal tubular disorders and the Academic Center of Excellence “Kidney & Hypertension”. He also is the coordinating PI of a national research consortium that studies the potential renoprotective role of potassium in chronic kidney disease. His research is supported by the Dutch Kidney Foundation, the Netherlands Organisation for Scientific Research, and the Novo Nordisk Foundation.
Hiddo Lambers Heerspink
Institution: University Medical Center Groningen
Location: Groningen, Netherlands
Hiddo Lambers Heerspink is affiliated with the Department of Clinical Pharmacy and Pharmacology of the University Medical Center Groningen, the Netherlands. He received his PhD degree from the medical faculty of the University Medical Center Groningen in 2008. He then worked as a post-doctoral fellow at The George Institute in Sydney, Australia where he investigated the effects of blood pressure lowering regimens on renal and cardiovascular outcomes in patients with renal impairment. Based on this work, he was awarded a young investigator grant and subsequently in 2015 a consolidator investigator grant from the Dutch organisation of scientific research.
Since 2010, Doctor Lambers Heerspink has held a position as a Clinical Pharmacologist at the University Medical Center Groningen. He is currently Professor Clinical Trials and Personalized Medicine. His main research interests include optimising treatment strategies and finding new therapeutic approaches to halt the progression of renal and cardiovascular disease. His particular clinical research interest is to identify determinants of individual treatment responses and ways to optimize drug response in individual patients. To achieve these goals he is involved in various international clinical trials and uses biomarkers and imaging techniques to unravel pathways and determinants of therapy response.
Institution: University College Dublin
Location: Dublin, Ireland
He received his medical education at University College Dublin, Ireland.
Following his internship at the Mater Misericordiae University Hospital in Dublin, he completed a residency in internal medicine at Hennepin County Medical Center in Minneapolis, Minnesota, USA.
He completed fellowship training programs in nephrology, critical care medicine, and clinical pharmacology at the University Of Chicago Hospitals in Chicago, Illinois, USA.
He is board-certified in nephrology, critical care medicine, and clinical pharmacology.
He practiced as an intensivist, nephrologist, and clinical pharmacologist at the University of Chicago Hospitals from 1996–2008, serving as the fellowship training program director in nephrology, also directing the Acute Dialysis Service.
He has a longstanding interest in research and education to improve the prevention, diagnosis, and therapy of acute kidney injury and nephrotoxicity, and the pharmacotherapy of patients with kidney disease. He is a member of several international consensus groups that have produced guidelines for research and practice in the field of acute kidney injury (ADQI, AKIN, KDOQI).
Since 2008, he has been the Professor of Clinical Pharmacology at University College Dublin, and a Consultant in Nephrology & Clinical Pharmacology at the Mater Misericordiae University Hospital. He is Chair of the Mater Misericordiae University Hospital Drugs & Therapeutics Committee. He is the Clinical Director of the UCD-Mater Clinical Research Centre. In 2011, he was appointed Associate Dean for International Affairs in the UCD School of Medicine and Medical Science. In 2012, he was appointed Director of the Dublin Centre for Clinical Research (DCCR) Consortium Network, and also Clinical Director of the Irish Clinical Research Infrastructure Network (ICRIN). Since December 2012, he has been the Dean and Head of the School of Medicine at UCD.
Institution: Medical University of Vienna
Location: Vienna, Austria
Dr. Oberbauer received his MD from the University of Vienna, Austria in 1990 and his MSc in Epidemiology from the Harvard School of Public Health, USA in 2005. He completed his fellowship in nephrology at the Universities of Vienna and Stanford, became Assistant Professor of Medicine in Vienna in 1996 and advanced to Associate Professor in 1999. In 2006 he was promoted to Director of the Renal Department of the Elisabethinen Hospital, Linz, Austria and 2014 to Director of the Department for Nephrology and Dialysis, Internal Medicine III, Medical University of Vienna.
Dr. Oberbauer has a longstanding clinical and scientific interest in renal transplantation and he has published numerous experimental as well as clinical papers in this field. He is a member of many international transplant societies, current chair of EKITA and is EIC of Transplant Int and on the editorial board of a number of other major international transplant journals. He has also received several academic awards for his scientific papers, which mainly focus on genetic and clinical epidemiology and new immunosuppressive strategies following renal transplantation.
Institution: Imperial College London
Location: London, UK
Institution: Radboud University Nijmegen
Location: Nijmegen, Netherlands
Jack F M Wetzels (1954) was born in Heerlen, The Netherlands. He studied Medicine at the Radboud University Nijmegen, and received his MD in 1980. He was trained in Internal Medicine and Nephrology at the Radboud University Nijmegen Medical center. He received his Ph.D. in 1989. From 1990 to 1992 he worked as a postdoctoral fellow under supervision of Robert W Schrier at the University of Colorado Health Sciences Center in Denver, CO, USA. Since 1992 he is working as academic nephrologist. In 2002 he was appointed Professor of Nephrology at the Department of Nephrology at Radboud University Nijmegen. His chair is committed to teaching and research with an emphasis on the diagnosis and treatment of patients with glomerular diseases.